Sutton Wealth Advisors’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,138
Closed -$16.5K 1281
2022
Q4
$16.5K Hold
1,138
0.01% 773
2022
Q3
$21.7K Buy
1,138
+19
+2% +$436 0.01% 632
2022
Q2
$20.3K Sell
1,119
-9
-0.8% -$187 0.01% 669
2022
Q1
$28.4K Sell
1,128
-11
-1% -$282 0.01% 594
2021
Q4
$31.4K Buy
1,139
+20
+2% +$579 0.01% 559
2021
Q3
$36.1K Hold
1,119
0.01% 500
2021
Q2
$34.2K Hold
1,119
0.01% 527
2021
Q1
$34.1K Hold
1,119
0.01% 510
2020
Q4
$22.1K Hold
1,119
0.01% 577
2020
Q3
$14.6K Buy
+1,119
New +$14.2K 0.01% 634
2020
Q2
Sell
-329
Closed -$4.71K 1259
2020
Q1
$4.71K Sell
329
-675
-67% -$14.3K ﹤0.01% 832
2019
Q4
$27.3K Hold
1,004
0.01% 494
2019
Q3
$28.7K Hold
1,004
0.02% 464
2019
Q2
$27.9K Sell
1,004
-152
-13% -$4.29K 0.02% 474
2019
Q1
$38.4K Buy
1,156
+152
+15% +$4.63K 0.02% 374
2018
Q4
$29.2K Hold
1,004
0.02% 408
2018
Q3
$46.2K Hold
1,004
0.03% 306
2018
Q2
$37.5K Hold
1,004
0.03% 367
2018
Q1
$29.7K Hold
1,004
0.02% 423
2017
Q4
$34.5K Hold
1,004
0.03% 376
2017
Q3
$36.3K Hold
1,004
0.03% 352
2017
Q2
$25.9K Sell
1,004
-255
-20% -$5.41K 0.02% 445
2017
Q1
$24.2K Buy
+1,259
New +$22.3K 0.02% 443

Other funds holding MYGN

Sutton Wealth Advisors's MYGN Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Myriad Genetics (MYGN) in Q1 2023, closing a stake of 1,138 shares — an estimated $16.5K sold.

Sutton Wealth Advisors first reported a position in MYGN in Q1 2017 and held it in 23 quarters. The position peaked at $46.2K in Q3 2018. 190 funds tracked by Wall St. Rank hold MYGN as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Myriad Genetics position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 1,138 Myriad Genetics shares in Q1 2023, an estimated $16.5K.
  • Sutton Wealth Advisors first reported a position in Myriad Genetics in Q1 2017 and held it in 23 quarters.
  • Sutton Wealth Advisors's Myriad Genetics position peaked at $46.2K in Q3 2018.
  • 190 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.